Immuneering CorporationIMRXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank50
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-5.17
↑ 48% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-10.02
Historical baseline
PeriodValueYoY Change
2025-5.17-378.3%
2024-1.08+72.3%
2023-3.91-54.2%
2022-2.53+80.0%
2021-12.69+9.0%
2020-13.95+54.8%
2019-30.83-